Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950129-04-005299
Filing Date
2004-07-29
Accepted
2004-07-29 17:03:04
Documents
5
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 ENCYSIVE PHARMACEUTICALS INC.- JUNE 30, 2004 h17054e10vq.txt 10-Q 96592
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 h17054exv31w1.txt EX-31.1 3448
3 CERTIFICATION OF CFO PURSUANT TO SECTION 302 h17054exv31w2.txt EX-31.2 3462
4 CERTIFICATION OF CEO PURSUANT TO SECTION 906 h17054exv32w1.txt EX-32.1 1449
5 CERTIFICATION OF CFO PURSUANT TO SECTION 906 h17054exv32w2.txt EX-32.2 1507
  Complete submission text file 0000950129-04-005299.txt   108593
Mailing Address
Business Address 6700 WEST LOOP SOUTH 4TH FLOOR BELLAIRE TX 77401 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20117 | Film No.: 04939732
SIC: 2834 Pharmaceutical Preparations